Support resources and financial assistance for Zoladex
You are probably feeling a range of emotions right now—shock, disbelief, fear, anxiety, sadness, anger, and maybe even depression.
Getting support from friends, family, and other people with your condition can help. Some people join a support group or an online community. You may find that talking with other people with your condition can ease some of your fears as you learn how others have coped.
Cost and savings assistance is available
If you need help with the cost of your co-pay, ask if you are eligible* for the Zoladex Co-pay Card. It could provide savings that make your co-pay lower. For more information, call 1-844-864-3014.
If you do not have insurance coverage for Zoladex, you may be eligible for financial help. Call the Zoladex Patient Assistance Program at 1-855-686-8725 to find out more.
*Customers are not eligible if prescriptions are paid for by any state or other federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA or DOD or TRICARE, or where prohibited by law. TerSera Therapeutics reserves the right to rescind, revoke, or amend this offer at any time.Sign up for savings
There are many organizations out there to help you through this
Young Survival Coalition® provides free educational resources, support networks, and online and in-person ways to connect.
Susan G. Komen is the largest breast cancer organization in the United States.
Living Beyond Breast Cancer works with women who have been diagnosed with breast cancer and their caregivers.
Us TOO provides peer-to-peer support and educational materials to men with prostate cancer and their families/caregivers.
For more information on breast cancer symptoms, treatments, and support, visit Breastcancer.org.
The Urology Care Foundation provides information for people with prostate cancer and their caregivers.
Visit the Prostate Care Foundation website to find free prostate cancer guides and other helpful resources.
By being listed here, the organizations above do not specifically endorse Zoladex.
- ZOLADEX® (goserelin acetate implant) [prescribing information]. Lake Forest, IL: TerSera Therapeutics LLC; 2017.
- Referenced with permission from the NCCN Guidelines for Patients, Breast Cancer. © National Comprehensive Cancer Network, Inc 2018. All rights reserved. Accessed December 18, 2018. To view the most recent and complete version of the guidelines, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.
- Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.3.2018. © National Comprehensive Cancer Network, Inc 2018. All rights reserved. Accessed December 18, 2018. To view the most recent and complete version of the guidelines, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.
- Referenced with permission from the NCCN Guidelines for Patients, Prostate Cancer. © National Comprehensive Cancer Network, Inc 2018. All rights reserved. Accessed December 28, 2018. To view the most recent and complete version of the guidelines, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use, or application and disclaims any responsibility for their application or use in any way.
- Mayo Clinic. Endometriosis diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/endometriosis/diagnosis-treatment/drc-20354661. Accessed January 14, 2019.
Important Safety Information About ZOLADEX
- If you are pregnant, ZOLADEX can cause harm to your unborn child. You should not receive ZOLADEX if you are pregnant, could become pregnant, or are nursing unless you are being treated to relieve symptoms of advanced breast cancer
- In both men and women ZOLADEX should not be administered if you are allergic to it, to any of its ingredients, or to similar hormone therapies
- Temporary worsening of symptoms of prostate or breast cancer including bone pain may sometimes develop during the first few weeks of ZOLADEX treatment. Also, rare cases of urinary tract blockage or spinal cord compression have been seen in men being treated for prostate cancer. Your doctor will monitor your condition closely for the first month of treatment
- In women, menstruation should stop with effective doses of ZOLADEX. Notify your doctor if regular menstruation persists
- In men, there is an increased risk for developing diabetes or worsening of glucose control, if you already have diabetes, if you are treated with drugs like ZOLADEX
- In men, there is a small increased risk of heart attack, sudden cardiac death, and stroke if you are treated with drugs like ZOLADEX
- Injection site injury has been reported following injection of ZOLADEX. Contact your doctor immediately if you experience any of the following symptoms: abdominal pain, abdominal bloating, shortness of breath, dizziness, light-headedness and/or any signs of confusion
- In women, the most common side effects are those resulting from reduction of estrogen. Those seen are hot flashes (flushes), headaches, vaginal dryness, emotional lability, change in libido, depression, sweating, and change in breast size
- In men, the most common side effects are those related to a loss of testosterone. Those seen are hot flashes, sexual dysfunction, decreased erections, pain, urinary tract symptoms, enlarged breasts, body weakness, upper respiratory infection, and loss of appetite
Approved Uses for ZOLADEX
- ZOLADEX is approved by the FDA for use in combination with another drug, flutamide, for the management of Stage T2b-T4 (Stage B2-C) prostate cancer. Treatment with ZOLADEX and flutamide should start 8 weeks before the start of radiation therapy and continue during radiation therapy.
- ZOLADEX is also approved by the FDA to lessen or relieve symptoms in patients with advanced prostate cancer.
- ZOLADEX is approved by the FDA to lessen or relieve symptoms of HR+ advanced breast cancer in premenopausal and perimenopausal women. Estrogen and progesterone receptor values may help predict whether ZOLADEX therapy is likely to be beneficial.
- ZOLADEX is indicated for the management of endometriosis, including pain relief and reducing endometrial lesions, for 6 months of therapy.
- ZOLADEX is also approved to thin the lining of the uterus (i.e., the endometrium) before a procedure that destroys this lining (a process called endometrial ablation), which helps with extreme uterine bleeding.
You are encouraged to report negative side effects of prescription drugs to the FDA.